Immune Design Revenue, Profits - IMDZ Quarterly Income Statement

Add to My Stocks
$3.45 $0.25 (7.81%) IMDZ stock closing price Sep 19, 2018 (Closing)

Fundamental analysis of IMDZ stock involves analyzing its financial statements, apart from checking the Immune Design stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the IMDZ stock. Revenue for year 2018 Q2 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest Immune Design profit and loss statement with those of the prior corresponding period. Also see Immune Design assets and Immune Design free cash flow for a complete valuation of IMDZ stock.

View and download details of revenue and profits for Immune Design for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Immune Design Revenues or Net Sales
-----5.47M2.06M8.21M1.13M1.86M
Cost Of Goods Sold (COGS)----------
Immune Design Gross Profit
-----5.42M1.92M8.13M-1.84M
Research & Development Expense11M10.31M8.54M10.24M10.86M14.03M12.01M11.17M11.38M10.57M
Selling General & Admin Expense4.01M3.99M4.34M3.9M3.88M4.13M4.45M9.55M3.94M3.91M
Income Before Depreciation Depletion Amortization-14.39M-13.81M-12.38M-13.65M-14.04M-12.74M-14.53M-12.59M-14.45M-12.64M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
Immune Design Pretax Income
-13.81M-13.3M-11.99M-13.41M-13.84M-12.62M-14.46M-12.44M-14.34M-12.29M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-13.81M-13.3M-11.98M-13.42M-13.85M-12.62M-14.45M-12.47M-14.35M-12.29M
Extraordinary Items & Discontinued Operations----------
Immune Design Profit/ Loss (Net Income)
-13.81M-13.3M-11.98M-13.42M-13.85M-12.62M-14.45M-12.47M-14.35M-12.29M
Average Shares used to compute Diluted EPS48.13M48.12M41.72M25.62M25.57M25.46M25.41M20.8M20.16M20.15M
Average Shares used to compute Basic EPS48.13M48.12M41.72M25.62M25.57M25.46M25.41M20.8M20.16M20.15M
Income Before Nonrecurring Items-13.81M-13.3M-11.98M-13.42M-13.85M-12.62M-14.45M-12.47M-14.35M-12.29M
Income from Nonrecurring Items----------
Immune Design Earnings Per Share Basic Net
-0.29-0.28-0.29-0.52-0.54-0.50-0.57-0.60-0.71-0.61
Immune Design Earnings Per Share Diluted Net
-0.29-0.28-0.29-0.52-0.54-0.50-0.57-0.60-0.71-0.61
EPS Diluted Before Nonrecurring Items-0.29-0.28-0.29-0.52-0.54-0.50-0.57-0.60-0.71-0.61
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Immune Design stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Immune Design revenue chart, implies that the company is growing. It has not been the case with Immune Design. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-13.81M for Immune Design for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the IMDZ income statement, one can check the Immune Design historical stock prices to check how the price has moved with time.

Immune Design Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
73.15
Dividend Yield
0%